As of 2024-12-15, the Relative Valuation of Seres Therapeutics Inc (MCRB) is (3.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Seres Therapeutics Inc based on Relative Valuation is -480.4%.
The range of the Relative Valuation is (3.09) - (2.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (3.09) - (2.87) | (3.34) |
| Upside | -451.9% - -426.4% | -480.4% |
| Date | P/E |
| 2024-12-13 | -5.89 |
| 2024-12-12 | -5.77 |
| 2024-12-11 | -6.03 |
| 2024-12-10 | -6.26 |
| 2024-12-09 | -5.73 |
| 2024-12-06 | -5.52 |
| 2024-12-05 | -5.46 |
| 2024-12-04 | -5.49 |
| 2024-12-03 | -5.88 |
| 2024-12-02 | -6.21 |
| 2024-11-29 | -6.57 |
| 2024-11-27 | -6.13 |
| 2024-11-26 | -5.88 |
| 2024-11-25 | -5.93 |
| 2024-11-22 | -5.15 |
| 2024-11-21 | -4.90 |
| 2024-11-20 | -5.45 |
| 2024-11-19 | -4.61 |
| 2024-11-18 | -3.88 |
| 2024-11-15 | -3.68 |
| 2024-11-14 | -3.97 |
| 2024-11-13 | -3.96 |
| 2024-11-12 | -4.45 |
| 2024-11-11 | -4.64 |
| 2024-11-08 | -4.79 |
| 2024-11-07 | -4.79 |
| 2024-11-06 | -5.06 |
| 2024-11-05 | -5.44 |
| 2024-11-04 | -5.41 |
| 2024-11-01 | -5.51 |
| 2024-10-31 | -5.49 |
| 2024-10-30 | -5.25 |
| 2024-10-29 | -5.17 |
| 2024-10-28 | -4.69 |
| 2024-10-25 | -4.72 |
| 2024-10-24 | -4.76 |
| 2024-10-23 | -5.07 |
| 2024-10-22 | -5.24 |
| 2024-10-21 | -5.45 |
| 2024-10-18 | -5.68 |
| 2024-10-17 | -5.65 |
| 2024-10-16 | -5.65 |
| 2024-10-15 | -5.47 |
| 2024-10-14 | -5.60 |
| 2024-10-11 | -5.41 |
| 2024-10-10 | -5.16 |
| 2024-10-09 | -4.98 |
| 2024-10-08 | -5.17 |
| 2024-10-07 | -5.55 |
| 2024-10-04 | -5.69 |